S. 5059 (119th)Congressional Activities
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
domestic policy
Sponsor
Cosponsors
Support
Bipartisan
Introduced
Jul 21, 2026
Discussions
Current stageCommittee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
Committee
Floor
President
Law
Congressional Activities
This tab collects committee work, CRS research, hearings, and amendment activity as those sources become available for the bill.
No congressional activity records are linked to this bill yet.